Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2026)
Top healthcare stocks in 2026 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Sector: Healthcare

Overview Zen Rating Price Value Growth Financials

Momentum Sentiment Forecast Dividends Due Diligence

Ticker	Company	Market Cap	ROE	ROA	ROCE	ROIC	D/E	Current Ratio	Gross Margin	Profit Margin	Operating Margin
PBYI	PUMA BIOTECHNOLOGY INC	$522.40M	20.90%	13.30%	24.27%	46.50%	0.39	2.91	74.80%	11.60%	15.00%
BHC	BAUSCH HEALTH COMPANIES INC	$2.20B	N/A	-4.30%	4.30%	3.40%	-14.45	1.44	71.80%	-10.10%	8.02%
BVS	BIOVENTUS INC	$1.14B	28.40%	8.00%	9.89%	13.10%	1.73	1.69	68.70%	9.40%	8.85%
ETON	ETON PHARMACEUTICALS INC	$1.52B	40.10%	12.40%	23.07%	66.30%	1.49	1.52	57.90%	12.00%	15.44%
PGEN	PRECIGEN INC	$2.68B	-1,063.90%	-211.90%	-104.99%	-77.10%	2.91	4.58	90.70%	-392.80%	-172.64%
ANIK	ANIKA THERAPEUTICS INC	$274.75M	-2.70%	-2.00%	-2.22%	-2.80%	0.34	4.48	62.20%	-3.10%	-2.96%
MD	PEDIATRIX MEDICAL GROUP INC	$2.16B	19.90%	8.10%	15.98%	34.10%	1.42	1.32	26.20%	9.00%	13.35%
INDV	INDIVIOR PHARMACEUTICALS INC	$4.18B	-216.10%	28.10%	115.07%	76.30%	-6.93	0.84	82.00%	26.70%	31.53%
AMPH	AMPHASTAR PHARMACEUTICALS INC	$1.11B	10.10%	4.70%	8.66%	9.40%	1.27	2.40	47.70%	10.80%	17.55%
HALO	HALOZYME THERAPEUTICS INC	$12.44B	180.60%	16.50%	27.03%	24.60%	16.96	2.71	82.40%	24.90%	36.28%
HAE	HAEMONETICS CORP	$5.54B	11.30%	4.00%	7.63%	8.50%	1.83	3.08	59.00%	7.10%	11.86%
FENC	FENNEC PHARMACEUTICALS INC	$356.98M	-11.70%	-4.90%	-3.47%	-8.50%	0.79	5.85	93.70%	-5.50%	-3.71%
ONC	BEONE MEDICINES LTD	$39.73B	14.20%	7.80%	14.29%	27.40%	0.77	3.41	88.90%	10.70%	16.45%
ICUI	ICU MEDICAL INC	$4.08B	1.40%	0.70%	2.07%	3.00%	0.85	2.43	39.10%	1.40%	3.33%
OMCL	OMNICELL INC	$1.66B	3.10%	2.00%	3.74%	10.10%	0.55	1.64	44.80%	3.10%	4.65%
OSCR	OSCAR HEALTH INC	$10.43B	38.50%	6.80%	23.86%	-62.00%	4.47	1.08	20.20%	3.60%	3.95%
INFU	INFUSYSTEM HOLDINGS INC	$268.68M	14.80%	8.60%	16.16%	14.40%	0.65	2.50	57.50%	6.00%	9.29%
SHC	SOTERA HEALTH CO	$5.20B	26.70%	5.00%	13.25%	11.40%	3.97	2.80	55.00%	13.40%	33.50%
CHE	CHEMED CORP	$6.55B	29.50%	17.50%	29.56%	60.50%	0.90	0.91	33.10%	10.60%	14.35%
CNC	CENTENE CORP	$34.02B	-24.00%	-6.30%	-9.40%	-17.50%	2.68	1.15	7.80%	-2.50%	-1.96%
CDNA	CAREDX INC	$3.38B	32.80%	24.80%	24.48%	69.80%	0.25	4.58	70.60%	24.20%	23.47%
REGN	REGENERON PHARMACEUTICALS INC	$77.54B	13.80%	10.60%	14.42%	15.10%	0.32	3.34	84.90%	27.90%	33.61%
HRMY	HARMONY BIOSCIENCES HOLDINGS INC	$2.16B	20.10%	14.10%	22.36%	52.00%	0.37	3.48	75.40%	18.90%	26.53%
AMRX	AMNEAL PHARMACEUTICALS INC	$6.25B	-326.80%	4.30%	12.81%	9.00%	113.35	2.21	39.30%	5.00%	11.89%
CORT	CORCEPT THERAPEUTICS INC	$12.73B	8.30%	6.40%	0.74%	0.90%	0.26	2.86	98.30%	6.50%	0.65%
BMY	BRISTOL MYERS SQUIBB CO	$115.76B	46.80%	10.30%	17.28%	19.30%	2.93	1.53	70.20%	18.90%	24.23%
LIVN	LIVANOVA PLC	$4.21B	15.40%	7.30%	7.43%	23.90%	0.99	1.45	68.10%	12.80%	9.77%
PGNY	PROGYNY INC	$2.10B	16.00%	10.70%	25.19%	31.50%	0.58	2.14	24.60%	6.00%	9.14%
KMDA	KAMADA LTD	$443.61M	8.40%	5.80%	8.30%	17.10%	0.42	4.06	40.80%	11.60%	14.45%
CAH	CARDINAL HEALTH INC	$55.75B	-59.70%	3.00%	18.90%	42.00%	-20.82	0.88	3.80%	0.70%	1.00%
TCMD	TACTILE SYSTEMS TECHNOLOGY INC	$505.37M	11.50%	9.20%	15.58%	38.50%	0.25	4.12	76.80%	7.10%	10.74%
CVS	CVS HEALTH CORP	$111.97B	6.40%	1.90%	5.33%	7.20%	2.18	0.87	14.20%	1.20%	2.14%
INNV	INNOVAGE HOLDING CORP	$1.23B	-1.10%	-0.50%	0.76%	1.20%	1.23	1.05	23.00%	-0.30%	0.27%
ELMD	ELECTROMED INC	$231.58M	23.40%	19.30%	26.57%	45.30%	0.23	4.69	78.50%	15.30%	19.46%
AUNA	AUNA SA	$394.49M	0.90%	0.20%	12.04%	11.40%	3.09	1.08	36.90%	0.30%	15.22%
AVAH	AVEANNA HEALTHCARE HOLDINGS INC	$2.66B	150.40%	13.80%	16.45%	16.60%	6.33	1.16	32.30%	10.60%	10.71%
ADUS	ADDUS HOMECARE CORP	$2.14B	9.60%	7.30%	11.69%	62.30%	0.27	1.69	32.40%	7.10%	10.20%
NEOG	NEOGEN CORP	$2.56B	-2.70%	-1.70%	-0.36%	-0.80%	0.58	3.90	47.40%	-6.30%	-1.27%
THC	TENET HEALTHCARE CORP	$21.49B	50.60%	7.40%	14.94%	16.40%	4.72	1.41	100.00%	9.90%	16.57%
CNMD	CONMED CORP	$1.36B	5.50%	2.40%	6.13%	8.10%	1.21	1.48	55.80%	4.10%	8.25%
PACS	PACS GROUP INC	$7.03B	27.20%	4.80%	8.96%	5.40%	4.09	0.91	16.60%	4.80%	7.43%
NRIX	NURIX THERAPEUTICS INC	$2.30B	-76.10%	-57.30%	-73.70%	-75.50%	0.33	6.34	100.00%	-928.40%	-929.18%
BMRN	BIOMARIN PHARMACEUTICAL INC	$10.53B	1.20%	0.80%	2.31%	3.70%	0.85	2.39	76.10%	2.10%	6.83%
JAZZ	JAZZ PHARMACEUTICALS PLC	$13.66B	21.40%	8.20%	10.15%	13.40%	1.31	1.78	88.40%	20.40%	19.53%
IRWD	IRONWOOD PHARMACEUTICALS INC	$593.21M	-57.40%	34.30%	95.15%	42.00%	-2.76	6.06	100.00%	33.40%	61.66%
STE	STERIS PLC	$21.23B	11.30%	7.60%	12.13%	21.50%	0.49	1.91	44.40%	13.30%	18.99%
DGX	QUEST DIAGNOSTICS INC	$25.44B	14.50%	6.40%	10.81%	17.00%	1.21	1.59	33.10%	9.20%	14.17%
LFST	LIFESTANCE HEALTH GROUP INC	$4.71B	3.40%	2.30%	4.04%	11.20%	0.48	1.38	33.60%	3.20%	4.87%
BCRX	BIOCRYST PHARMACEUTICALS INC	$2.06B	N/A	-77.60%	-87.65%	-34.50%	-2.23	2.32	97.80%	-40.90%	-32.52%
VTRS	VIATRIS INC	$19.81B	-2.80%	-1.10%	-0.63%	-0.90%	1.46	1.59	34.80%	-2.80%	-1.24%
BTSG	BRIGHTSPRING HEALTH SERVICES INC	$12.40B	19.00%	5.90%	12.77%	15.20%	1.92	1.59	12.40%	2.50%	3.94%
RPRX	ROYALTY PHARMA PLC	$32.53B	8.30%	4.10%	6.13%	4.50%	1.03	2.80	100.00%	32.10%	46.37%
MMSI	MERIT MEDICAL SYSTEMS INC	$5.26B	9.10%	5.30%	8.71%	12.10%	0.71	4.20	49.50%	9.20%	14.33%
PRGO	PERRIGO CO PLC	$2.13B	-56.00%	-20.30%	-22.59%	-24.20%	2.03	2.32	33.30%	-41.90%	-35.73%
EXEL	EXELIXIS INC	$14.75B	42.50%	32.00%	48.56%	49.90%	0.35	3.46	96.50%	35.30%	42.51%
DCTH	DELCATH SYSTEMS INC	$531.59M	0.50%	0.40%	2.07%	3.40%	0.13	9.83	87.10%	0.60%	2.68%
ARQT	ARCUTIS BIOTHERAPEUTICS INC	$3.28B	15.10%	6.50%	13.15%	12.00%	1.22	2.92	91.10%	6.10%	9.30%
VMD	VIEMED HEALTHCARE INC	$366.03M	10.30%	7.20%	14.12%	21.60%	0.41	1.13	57.50%	4.80%	7.32%
PTGX	PROTAGONIST THERAPEUTICS INC	$8.96B	12.00%	11.20%	9.94%	17.10%	0.05	21.71	100.00%	29.40%	29.91%
BWAY	BRAINSWAY LTD	$478.34M	12.70%	8.10%	11.96%	34.40%	0.54	3.59	75.30%	15.60%	19.57%
ATRC	ATRICURE INC	$2.89B	2.10%	1.60%	2.98%	8.50%	0.31	4.22	76.30%	1.90%	3.11%
DXCM	DEXCOM INC	$32.10B	36.20%	14.80%	31.68%	28.80%	1.46	1.73	62.50%	20.10%	26.13%
CON	CONCENTRA GROUP HOLDINGS PARENT INC	$4.79B	47.30%	6.90%	13.92%	12.80%	5.25	1.38	29.30%	8.70%	16.08%
UFPT	UFP TECHNOLOGIES INC	$2.28B	16.70%	10.90%	15.97%	24.90%	0.48	3.00	28.50%	11.40%	15.26%
PARK	PARK DENTAL PARTNERS INC	$93.16M	-18.30%	-2.00%	-4.69%	-4.70%	5.25	1.12	11.10%	-1.40%	-2.81%
TAK	TAKEDA PHARMACEUTICAL CO LTD	$58.53B	-2.20%	-1.10%	1.42%	2.10%	1.07	1.14	65.50%	-3.50%	3.98%
VCEL	VERICEL CORP	$2.06B	6.90%	5.00%	5.71%	6.20%	0.36	5.04	74.60%	7.90%	8.40%
AUPH	AURINIA PHARMACEUTICALS INC	$2.18B	59.00%	44.90%	23.75%	28.20%	0.29	5.42	90.40%	100.80%	52.80%
DH	DEFINITIVE HEALTHCARE CORP	$104.72M	-78.50%	-26.90%	-43.61%	-102.30%	2.14	1.86	75.20%	-72.30%	-68.92%
BLCO	BAUSCH & LOMB CORP	$5.65B	-2.70%	-1.20%	2.64%	3.60%	1.16	1.55	61.40%	-3.20%	5.94%
GILD	GILEAD SCIENCES INC	$183.41B	-16.30%	-5.80%	-2.50%	-2.50%	3.18	1.27	79.60%	-10.60%	-3.14%
COR	CENCORA INC	$62.99B	106.40%	3.30%	16.35%	43.60%	26.41	0.94	4.00%	0.80%	1.21%
NEO	NEOGENOMICS INC	$2.14B	-6.30%	-3.80%	-4.17%	-7.20%	0.72	3.60	43.90%	-6.80%	-6.78%
CLOV	CLOVER HEALTH INVESTMENTS CORP	$2.55B	-5.40%	-2.90%	-4.63%	-9.10%	0.91	1.50	18.60%	-0.70%	-0.74%
CI	CIGNA GROUP	$74.66B	15.20%	4.10%	9.35%	17.80%	2.68	0.85	9.10%	2.30%	3.36%
EOLS	EVOLUS INC	$496.04M	N/A	-15.00%	-11.70%	-9.00%	-9.03	1.70	66.70%	-10.80%	-5.52%
NHC	NATIONAL HEALTHCARE CORP	$3.62B	12.90%	9.10%	14.25%	17.50%	0.36	1.86	100.00%	9.00%	11.89%
PTCT	PTC THERAPEUTICS INC	$5.00B	N/A	-1.30%	4.77%	10.30%	-20.66	3.39	93.00%	-3.80%	11.72%
HCM	HUTCHMED (CHINA) LTD	$2.36B	1.40%	1.00%	1.53%	1.60%	0.37	5.64	41.60%	3.30%	4.08%
PDEX	PRO DEX INC	$199.47M	31.10%	19.80%	30.60%	30.90%	0.56	4.10	31.40%	17.60%	24.28%
TKNO	ALPHA TEKNOVA INC	$441.32M	-24.90%	-16.50%	-17.75%	-14.90%	0.53	4.49	34.60%	-38.40%	-36.16%
CCLD	CARECLOUD INC	$82.86M	6.10%	3.30%	15.40%	35.40%	4.39	1.02	46.50%	2.30%	7.23%
ASND	ASCENDIS PHARMA A	$14.66B	186.90%	44.00%	16.92%	30.30%	0.59	2.99	91.30%	70.80%	29.43%
ZVRA	ZEVRA THERAPEUTICS INC	$617.00M	32.80%	20.50%	29.52%	42.70%	0.39	5.17	95.50%	42.80%	55.12%
KNSA	KINIKSA PHARMACEUTICALS INTERNATIONAL PLC	$6.13B	13.70%	10.10%	15.76%	24.30%	0.37	3.90	89.80%	9.60%	13.59%
HSIC	HENRY SCHEIN INC	$9.48B	12.40%	3.60%	8.79%	11.20%	2.11	1.32	31.30%	3.00%	5.10%
NVST	ENVISTA HOLDINGS CORP	$3.64B	3.10%	1.70%	5.63%	11.80%	0.82	2.43	55.20%	3.30%	9.43%
IQV	IQVIA HOLDINGS INC	$42.91B	22.00%	4.70%	11.39%	17.40%	3.82	0.71	33.00%	8.10%	14.13%
LH	LABCORP HOLDINGS INC	$25.44B	11.60%	5.40%	8.90%	12.40%	1.15	1.80	28.90%	7.00%	10.17%
GMED	GLOBUS MEDICAL INC	$10.25B	11.60%	10.00%	12.83%	27.90%	0.15	4.62	68.50%	17.00%	20.44%
HSTM	HEALTHSTREAM INC	$986.85M	6.00%	4.10%	6.92%	56.80%	0.46	1.06	65.10%	6.60%	8.60%
ANIP	ANI PHARMACEUTICALS INC	$1.63B	19.60%	7.50%	13.15%	16.80%	1.50	2.91	60.40%	11.00%	16.27%
LLY	ELI LILLY & CO	$1.10T	92.60%	22.00%	35.54%	32.50%	3.20	1.36	83.40%	33.50%	42.17%
SGHT	SIGHT SCIENCES INC	$462.19M	-50.60%	-26.70%	-29.20%	-50.00%	0.98	4.95	88.00%	-35.70%	-29.55%
VCYT	VERACYTE INC	$3.47B	8.60%	8.00%	8.15%	49.40%	0.07	9.16	71.70%	20.40%	20.65%
OMER	OMEROS CORP	$1.37B	-109.40%	46.00%	70.76%	25.50%	-6.59	1.95	96.40%	324.90%	353.38%
PHG	KONINKLIJKE PHILIPS NV	$23.97B	7.80%	3.20%	7.84%	11.90%	1.46	1.32	45.20%	5.00%	8.54%
OPRX	OPTIMIZERX CORP	$158.69M	3.60%	2.70%	7.41%	24.80%	0.25	5.58	73.20%	4.70%	11.61%
TMO	THERMO FISHER SCIENTIFIC INC	$245.16B	13.30%	6.30%	9.21%	14.90%	1.15	1.55	40.80%	15.00%	19.49%
DERM	JOURNEY MEDICAL CORP	$160.31M	-20.20%	-6.60%	-4.60%	-9.60%	2.06	1.59	65.50%	-9.00%	-3.55%

Healthcare Industries

Industry	Stocks	1d %	1w %	1m %	1y %	P/E ratio	P/B Ratio	ROE	ROA	ROCE	Upside/Downside	Consensus
Biotechnology	605	-3.31%	-4.41%	-12.70%	-72.42%	14.11x	4.88x	-11.01%	-10.03%	-8.07%	+80.04%	Strong Buy
Diagnostics & Research	50	+0.10%	+0.57%	+9.91%	+27.17%	11.79x	4.71x	-29.33%	+5.36%	+11.40%	+2.64%	Buy
Drug Manufacturers - General	20	-1.75%	+0.62%	+1.14%	+24.37%	39.28x	7.83x	+23.62%	+10.74%	+19.12%	+25.37%	Buy
Drug Manufacturers - Specialty & Generic	75	-1.97%	-0.73%	-5.30%	-94.19%	-1.74x	2.35x	-1.68%	+1.60%	+7.12%	+194.41%	Buy
Healthcare Plans	10	-0.24%	+3.91%	-0.88%	+18.01%	55.82x	2.32x	+10.70%	+3.28%	+8.15%	+11.54%	Buy
Health Information Services	50	-0.34%	-0.87%	+0.40%	-44.85%	11.95x	4.03x	+7.12%	+4.01%	+9.09%	+17.05%	Buy
Medical Care Facilities	48	-0.09%	+1.43%	-0.27%	-53.67%	16.80x	5.73x	-42.74%	+7.27%	+14.52%	+13.50%	Buy
Medical Devices	132	-0.38%	+0.33%	-1.59%	-95.34%	22.66x	3.06x	-9.45%	+5.29%	+9.68%	+27.22%	Strong Buy
Medical Distribution	8	+0.84%	+3.87%	+3.55%	+23.59%	26.62x	-190.64x	-76.01%	+4.11%	+24.39%	+6.81%	Buy
Medical Instruments & Supplies	50	-0.46%	+1.98%	+2.84%	+3.00%	44.54x	3.37x	+8.63%	+7.24%	+11.01%	+14.77%	Buy

Healthcare Stocks FAQ

What are the best healthcare stocks to buy right now in Oct 2026?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best healthcare stocks to buy right now are:

1. Puma Biotechnology (NASDAQ:PBYI)

Puma Biotechnology (NASDAQ:PBYI) is the #1 top healthcare stock out of 1048 with a Zen Rating of A. Stocks with a rating of A have had an average return of +28.5% per year. Learn more.

The Component Grade breakdown for Puma Biotechnology (NASDAQ:PBYI) is: Value: A, Growth: C, Momentum: A, Sentiment: C, Safety: C, Financials: A, and AI: B.

Puma Biotechnology (NASDAQ:PBYI) has a Due Diligence Score of 48, which is 21 points higher than the healthcare sector average of 27. It passed 15 out of 33 due diligence checks and has strong fundamentals. Puma Biotechnology has seen its stock return 91.3% over the past year, overperforming other healthcare stocks by 169 percentage points.

Puma Biotechnology has an average 1 year price target of $6.00, a downside of -40.71% from Puma Biotechnology's current stock price of $10.12.

Puma Biotechnology stock has a consensus Hold recommendation according to Wall Street analysts. Of the 1 analyst covering Puma Biotechnology, 0% have issued a Strong Buy rating, 0% have issued a Buy, 100% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Bausch Health Companies (NYSE:BHC)

Bausch Health Companies (NYSE:BHC) is the #2 top healthcare stock out of 1048 with a Zen Rating of A. Stocks with a rating of A have had an average return of +28.5% per year. Learn more.

The Component Grade breakdown for Bausch Health Companies (NYSE:BHC) is: Value: A, Growth: B, Momentum: C, Sentiment: A, Safety: B, Financials: C, and AI: C.

Bausch Health Companies (NYSE:BHC) has a Due Diligence Score of 6, which is -21 points lower than the healthcare sector average of 27. Although this number is below the industry average, our proven quant model rates BHC as a "A".It passed 2 out of 33 due diligence checks and has weak fundamentals. Bausch Health Companies has seen its stock lose -3.6% over the past year, overperforming other healthcare stocks by 74 percentage points.

Bausch Health Companies has an average 1 year price target of $9.00, an upside of 52.8% from Bausch Health Companies's current stock price of $5.89.

Bausch Health Companies stock has a consensus Hold recommendation according to Wall Street analysts. Of the 1 analyst covering Bausch Health Companies, 0% have issued a Strong Buy rating, 0% have issued a Buy, 100% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Bioventus (NASDAQ:BVS)

Bioventus (NASDAQ:BVS) is the #3 top healthcare stock out of 1048 with a Zen Rating of A. Stocks with a rating of A have had an average return of +28.5% per year. Learn more.

The Component Grade breakdown for Bioventus (NASDAQ:BVS) is: Value: B, Growth: B, Momentum: B, Sentiment: C, Safety: B, Financials: A, and AI: C.

Bioventus (NASDAQ:BVS) has a Due Diligence Score of 48, which is 21 points higher than the healthcare sector average of 27. It passed 15 out of 33 due diligence checks and has strong fundamentals. Bioventus has seen its stock return 106.39% over the past year, overperforming other healthcare stocks by 184 percentage points.

Bioventus has an average 1 year price target of $16.00, an upside of 17.99% from Bioventus's current stock price of $13.56.

Bioventus stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 3 analysts covering Bioventus, 66.67% have issued a Strong Buy rating, 33.33% have issued a Buy, 0% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the healthcare stocks with highest dividends?

Out of 79 healthcare stocks that have issued dividends in the past year, the 3 healthcare stocks with the highest dividend yields are:

1. Conmed (NYSE:CNMD)

Conmed (NYSE:CNMD) has an annual dividend yield of N/A, which is N/A percentage points lower than the healthcare sector average of 2.25%. Conmed's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Conmed's dividend has not shown consistent growth over the last 10 years.

Conmed's dividend payout ratio of 10.8% indicates that its dividend yield is sustainable for the long-term.

2. Cumberland Pharmaceuticals (NASDAQ:CPIX)

Cumberland Pharmaceuticals (NASDAQ:CPIX) has an annual dividend yield of 20.92%, which is 19 percentage points higher than the healthcare sector average of 2.25%.

Cumberland Pharmaceuticals's dividend payout ratio of -411% indicates that its high dividend yield might not be sustainable for the long-term.

3. Spok Holdings (NASDAQ:SPOK)

Spok Holdings (NASDAQ:SPOK) has an annual dividend yield of 11.52%, which is 9 percentage points higher than the healthcare sector average of 2.25%. Spok Holdings's dividend payout is not stable, having dropped more than 10% one times in the last 10 years. Spok Holdings's dividend has shown consistent growth over the last 10 years.

Spok Holdings's dividend payout ratio of 207.9% indicates that its high dividend yield might not be sustainable for the long-term.

Why are healthcare stocks down?

Healthcare stocks were down -1.35% in the last day, and down -0.79% over the last week. Syndax Pharmaceuticals was the among the top losers in the healthcare sector, dropping -15.71% yesterday.

Syndax Pharmaceuticals shares are trading lower after the company announced that the MAXPIRe Phase 2 trial of axatilimab in idiopathic pulmonary fibrosis did not meet its primary endpoint of the annualized rate of decline in forced vital capacity.

What are the most undervalued healthcare stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued healthcare stocks right now are:

1. Ironwood Pharmaceuticals (NASDAQ:IRWD)

Ironwood Pharmaceuticals (NASDAQ:IRWD) is the most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Ironwood Pharmaceuticals has a valuation score of 86, which is 69 points higher than the healthcare sector average of 17. It passed 6 out of 7 valuation due diligence checks.

Ironwood Pharmaceuticals's stock has gained 142.57% in the past year. It has overperformed other stocks in the healthcare sector by 220 percentage points.

2. Jazz Pharmaceuticals (NASDAQ:JAZZ)

Jazz Pharmaceuticals (NASDAQ:JAZZ) is the second most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Jazz Pharmaceuticals has a valuation score of 86, which is 69 points higher than the healthcare sector average of 17. It passed 6 out of 7 valuation due diligence checks.

Jazz Pharmaceuticals's stock has gained 55.68% in the past year. It has overperformed other stocks in the healthcare sector by 133 percentage points.

3. Embecta (NASDAQ:EMBC)

Embecta (NASDAQ:EMBC) is the third most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Embecta has a valuation score of 57, which is 40 points higher than the healthcare sector average of 17. It passed 4 out of 7 valuation due diligence checks.

Embecta's stock has dropped -53.56% in the past year. It has overperformed other stocks in the healthcare sector by 24 percentage points.

Are healthcare stocks a good buy now?

59.17% of healthcare stocks rated by analysts are a strong buy right now. On average, analysts expect healthcare stocks to rise by 40.26% over the next year.

4.04% of healthcare stocks have a Zen Rating of A (Strong Buy), 13.26% of healthcare stocks are rated B (Buy), 48.61% are rated C (Hold), 27.4% are rated D (Sell), and 6.69% are rated F (Strong Sell).

What is the average p/e ratio of the healthcare sector?

The average P/E ratio of the healthcare sector is 30.08x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.

Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2026)
Top healthcare stocks in 2026 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Healthcare Industries

Healthcare Stocks FAQ

1. Puma Biotechnology (NASDAQ:PBYI)

2. Bausch Health Companies (NYSE:BHC)

3. Bioventus (NASDAQ:BVS)

1. Conmed (NYSE:CNMD)

2. Cumberland Pharmaceuticals (NASDAQ:CPIX)

3. Spok Holdings (NASDAQ:SPOK)

1. Ironwood Pharmaceuticals (NASDAQ:IRWD)

2. Jazz Pharmaceuticals (NASDAQ:JAZZ)

3. Embecta (NASDAQ:EMBC)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcareBest Healthcare Stocks to Buy Now (2026)Top healthcare stocks in 2026 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Healthcare Industries

Healthcare Stocks FAQ

1. Puma Biotechnology (NASDAQ:PBYI)

2. Bausch Health Companies (NYSE:BHC)

3. Bioventus (NASDAQ:BVS)

1. Conmed (NYSE:CNMD)

2. Cumberland Pharmaceuticals (NASDAQ:CPIX)

3. Spok Holdings (NASDAQ:SPOK)

1. Ironwood Pharmaceuticals (NASDAQ:IRWD)

2. Jazz Pharmaceuticals (NASDAQ:JAZZ)

3. Embecta (NASDAQ:EMBC)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2026)
Top healthcare stocks in 2026 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.